Potassium Chloride Tablet, Extended Release
Product Images NDC 67296-2243

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 67296-2243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (10 mEq K)

This is a description for an extended-release tablet containing 750 mg of Potassium chloride, USP, equivalent to 10 mEq of potassium. The dosage must be adjusted according to individual patient needs. It is recommended to store the tablets at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (55° to 86°F). The tablets should be dispensed in a tight container with a child-resistant closure and kept tightly closed. The tablets feature Micro-Dispersible Technology® and should be kept out of reach of children. Manufactured by Upsher-Smith Laboratories, LLC, in Maple Grove, MN 55369. The product may be covered by U.S. patents.*

FDA Label Image

Principal Display Panel (20 mEq K)

This text provides information on an extended-release tablet containing potassium chloride (equivalent to potassium 20 mEq). It advises on the usual dosage, storage conditions (20-25°C), and dispense in a tight container. The product utilizes Micro-Dispersible Technology and is manufactured by Upsher-Smith Laboratories. The text also mentions the need for dosage adjustment based on individual needs and warns to keep out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.